Literature DB >> 25926397

Abdominal Distension and Escherichia coli Peritonitis in Mice Lacking Myeloid Differentiation Factor 88.

Linda K Johnson1, Antin Yn Widi2, Serrin Rowarth3, Alan G Baxter3.   

Abstract

Here we describe the gross and microscopic findings of naturally occurring, β-hemolytic Escherichia coli peritonitis in B6.129-Myd88(tm1Aki) male and female mice. Over approximately 5 mo, 10 homozygous mutant mice deficient in myeloid differentiation factor 88 (C57BL/6 strain; male and female) that had not been used in research protocols developed rapid-onset abdominal swelling associated with copious viscous ascites. Each mouse developed an anterior peritonitis, primarily involving the parietal peritoneum and the visceral surface of the spleen, liver, diaphragm, and stomach. Inflammation was confined to the organ surfaces, with no indication of septicemia or grossly apparent gastrointestinal perforation or other tissue compromise that would initiate peritonitis. Peritonitis was likely attributable to compromised antibacterial innate immunity; cohoused, similarly immunodeficient littermates did not develop similar clinical signs. An unusual finding in all cases was mesothelial cell hyperplasia and hypertrophy. Although the underlying innate immune deficiency accounts for much of the observed pathology, the remarkable mesothelial cell morphology and the episodic nature of the peritonitis in some littermates and not others remain unexplained.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926397      PMCID: PMC4408897     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  18 in total

Review 1.  Heads up! How the intestinal epithelium safeguards mucosal barrier immunity through the inflammasome and beyond.

Authors:  Elke Cario
Journal:  Curr Opin Gastroenterol       Date:  2010-11       Impact factor: 3.287

2.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

3.  Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome.

Authors:  Aimon K Alkanani; Naoko Hara; Egil Lien; Diana Ir; Cassandra V Kotter; Charles E Robertson; Brandie D Wagner; Daniel N Frank; Danny Zipris
Journal:  Diabetes       Date:  2013-12-18       Impact factor: 9.461

Review 4.  Immune adaptations that maintain homeostasis with the intestinal microbiota.

Authors:  Lora V Hooper; Andrew J Macpherson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

5.  Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis.

Authors:  Socorro Miranda-Hernandez; Nicole Gerlach; Julie M Fletcher; Erik Biros; Matthias Mack; Heinrich Körner; Alan G Baxter
Journal:  J Immunol       Date:  2011-06-17       Impact factor: 5.422

6.  Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.

Authors:  Cornelis van 't Veer; Petra S van den Pangaart; Daniëlle Kruijswijk; Sandrine Florquin; Alex F de Vos; Tom van der Poll
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

7.  Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.

Authors:  O Takeuchi; K Hoshino; S Akira
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

9.  Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides.

Authors:  A L Frantz; E W Rogier; C R Weber; L Shen; D A Cohen; L A Fenton; M E C Bruno; C S Kaetzel
Journal:  Mucosal Immunol       Date:  2012-04-11       Impact factor: 7.313

10.  Development of fatal intestinal inflammation in MyD88 deficient mice co-infected with helminth and bacterial enteropathogens.

Authors:  Libo Su; Yujuan Qi; Mei Zhang; Meiqian Weng; Xichen Zhang; Chienwen Su; Hai Ning Shi
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.